• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
JLG
Click for more information
2.85% $3.75

JOHNS LYNG GROUP LIMITED - News & Media

Market Cap $1.044B  ! watchlist Created with Sketch. Add to my watchlist
Industrials Conglomerates

Johns Lyng Group Limited is an Australia-based integrated building services provider,... Johns Lyng Group Limited is an Australia-based integrated building services provider, delivering building and restoration services across Australia and the United States. The Company’s core business is built on its ability to rebuild and restore a variety of properties and contents after damage by insurable events, including impact, weather and fire events. The Company operates through four segments: Insurance Building and Restoration Services, Commercial Building Services, Commercial Construction, and Other. Its Insurance Building and Restoration services include 24/7 emergency service, international availability, fire damage, vehicle and structural impact, storm damage and tree removal, mold and biohazard, contents and surface restoration, building maintenance, total claims handling, and hazardous waste removal. Its Commercial Services include project management, warehousing & logistics, reactive maintenance, preventative maintenance, floorcovering, retail shopfitting, and others.More

Articles & Videos

Johns Lying Group (ASX:JLG) acquires SAA and Linkfire in $61.8m deal

John Lying Group (ASX:JLG) has agreed to acquire Smoke Alarms Australia (SAA) and 70 per cent of LinkFire in a combined deal worth $61.8m.

05 Jul 2023 12:24 (AEST)



(20min delay)
Last
$3.75 		Change
-0.110(2.85%) 		Mkt cap ! $1.044B
Open High Low Value Volume
$3.84 $3.88 $3.73 $10.04M 2.655M

Buyers (Bids)

No. Vol. Price($)
10 87781 $3.74
 

Sellers (Offers)

Price($) Vol. No.
$3.79 38487 3
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
Last
$3.78 		  Change
-0.110 ( 2.68 %)
Open High Low Volume
$3.85 $3.87 $3.73 1682939
Last updated 15.59pm 30/08/2024 ?
JLG (ASX) Chart

Top Stories

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

PYC Therapeutics Ltd has received a special designation from the FDA for its drug PYC-001 to treat a childhood-originating eye disease.
Lendlease sells off US east coast construction operations in latest global divestment push Lendlease (ASX:LLC) has confirmed it's inked a deal with Consigil Construction to sell off its US-based East Coast construction operations.
Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch The Consumer Staples sector's resilience across different market conditions makes it a compelling choice in a weaker economy.
Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24 Harvey Norman Holdings Ltd has reported its financial results for the 2024 fiscal year, reporting a fall in profit and sales.
The Calmer Co’s Anthony Noble reflects on record breaking FY24 The Calmer Co’s MD & CEO, Anthony Noble, highlights the company’s impressive financial performance for FY24.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.